The Valley Desk

NCT00448864 · Interventional trial

Efficacy Study of Recombinant Protein (Ecallantide) to Reduce Blood Loss During Primary Coronary Bypass Grafting or Valve Repair/Replacement

Overall registry status Terminated

Phase 2

Conditions Blood Loss, Surgical

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov